|
Jul 16
|
Sarepta Therapeutics Stock Soars on Beleaguered Drugmaker's Restructuring Plan
|
|
Jul 16
|
Sarepta Therapeutics to Restructure, Lay Off 500 Workers
|
|
Jul 16
|
Sarepta Therapeutics Stock Is Surging After The Bell: What's Going On?
|
|
Jul 16
|
Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label
|
|
Jul 16
|
JPMorgan Cuts Sarepta (SRPT) PT, Keeps Overweight Rating
|
|
Jul 16
|
Sarepta to lay off about 500 employees after Duchenne gene therapy setbacks
|
|
Jul 15
|
Sarepta Therapeutics Halts ELEVIDYS Shipments for Non-Ambulatory DMD Patients
|
|
Jun 27
|
2 Beaten-Down Stocks to Avoid
|
|
Jun 26
|
Sarepta Therapeutics (NasdaqGS:SRPT) Faces Shipment Suspension Amid Safety Update
|
|
Jun 24
|
Sarepta Therapeutics (SRPT) Tumbles 44% W/W as Analyst Cuts Price Target by 63%
|
|
Jun 20
|
Stocks Settle Mostly Lower as Chip Makers Fall
|
|
Jun 20
|
Gene Therapy Stocks Fall Amid More Turmoil at FDA
|
|
Jun 20
|
Gene Therapy Was the Biggest Idea in Biotech. Now It Has Lost Support on Wall Street.
|
|
Jun 20
|
2 Growth Stocks with All-Star Potential and 1 to Ignore
|
|
Jun 19
|
SanDisk initiated, Analog Devices upgraded: Wall Street’s top analyst calls
|
|
Jun 18
|
Roku upgraded, Sarepta downgraded: Wall Street’s top analyst calls
|
|
Jun 17
|
Sarepta Therapeutics (NasdaqGS:SRPT) SRP-9003 Gene Therapy Earns FDA Platform Technology Designation
|
|
Jun 17
|
Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls
|
|
Jun 17
|
Company News for Jun 17, 2025
|
|
Jun 17
|
Morning Movers: Sage Therapeutics surges after deal to be acquired by Supernus
|